相关实验视频
Updated: Jul 15, 2026

10:20
Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
Published on: June 16, 2008
努力打击HIV-1,但只有在必要时才能这样做
1Treatment Action Group, New York, NY 10001, USA. markharrington@aol.com
Lancet (London, England)
|July 21, 2000
概括
当CD4计数下降到350细胞/微米L以下时,开始治疗HIV-1感染的组合抗逆转录病毒疗法平衡了益处与风险. 这种方法有助于延迟或预防HIV-1患者的免疫损伤,艾滋病和死亡.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 传染性疾病 传染性疾病
背景情况:
- 联合抗逆转录病毒疗法 (cART) 对于控制HIV-1感染至关重要.
- 由于潜在的毒性和耐药性,启动cART的最佳时间仍然是一个关键的临床问题.
- 艾滋病毒-1感染带来了独特的挑战:没有治愈,药物毒性和多药耐药性的风险.
研究的目的:
- 讨论证明采取平衡方法启动cART治疗HIV-1的数据.
- 评估随机对照试验 (RCT) 的可行性,以确定最佳的cART启动时间.
- 为了平衡早期治疗的好处与累积副作用和耐药性的风险.
主要方法:
- 随机对照试验对cART疗效的数据的审查.
- 分析与不同治疗开始门相关的风险和益处.
- 讨论临床监测参数:CD4细胞计数和病毒载量.
主要成果:
- cART对CD4细胞计数低于350细胞/μL的个体有益.
- 仔细监测可以延迟启动,可能防止免疫损伤和疾病进展.
- 太早开始治疗的风险超过了由于副作用和耐药性的益处;太晚开始会增加死亡率.
结论:
- 当CD4计数低于350细胞/微升时,在仔细监测下启动cART是一种合理的方法.
- 该战略旨在延迟或预防艾滋病和死亡,同时尽量减少累积药物毒性和耐药性.
- 需要进一步的RCT来完善HIV-1感染的最佳治疗启动策略.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

